Search research articles
Contact Us
Filters
Showing results (91-100 of 159) with videos related to
Page
of 16
Sort By:
The Oncologist
|
March 3, 2023
Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab
Robert Motzer, Saby George, Jaime R Merchan, et al.
Journal of the National Cancer Institute
|
April 11, 2026
Belzutifan Efficacy in Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma Versus Natural History Control Arm
W Marston Linehan, Thomas Jemielita, Jerry Cornell, et al.
Pediatric Blood & Cancer
|
July 13, 2011
Haploidentical non-myeloablative stem cell transplantation as salvage for graft failure in a patient with juvenile myelomonocytic leukemia
Guilherme F Perini, Fábio R Kerbauy, Juliana Folloni Fernandes, et al.
The Journal of Biological Chemistry
|
November 25, 1985
The biosynthesis, processing, and secretion of laminin by human choriocarcinoma cells
B P Peters, R J Hartle, R F Krzesicki, et al.
The Journal of Biological Chemistry
|
February 10, 1980
Synthesis and secretion of human chorionic gonadotropin subunits by cultured human malignant cells
R W Ruddon, C A Hanson, A H Bryan, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 21, 2017
Pathogenesis of chronic cluster headache and bouts: role of tryptamine, arginine metabolism and α<sub>1</sub>-agonists
G D'Andrea, G Bussone, P Di Fiore, et al.
Neuro-Oncology Advances
|
April 30, 2026
Phase 1 LITESPARK-001 study of belzutifan in participants with advanced solid tumors: Results of the glioblastoma expansion cohort
Roy E Strowd, Macarena de la Fuente, Todd M Bauer, et al.
Cancer Research
|
July 15, 1994
N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts
I Nishimori, F Perini, K P Mountjoy, et al.
Future Oncology (London, England)
|
October 26, 2023
LITESPARK-012: pembrolizumab plus lenvatinib with or without belzutifan or quavonlimab for advanced renal cell carcinoma
Toni K Choueiri, Thomas Powles, Martin H Voss, et al.
European Urology Oncology
|
August 15, 2019
Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden
Tushar Srivastava, Vimalanand S Prabhu, Haojie Li, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 159) with videos related to
Sort By:
Page
of 16
The Oncologist
|
March 3, 2023
Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab
Robert Motzer, Saby George, Jaime R Merchan, et al.
Journal of the National Cancer Institute
|
April 11, 2026
Belzutifan Efficacy in Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma Versus Natural History Control Arm
W Marston Linehan, Thomas Jemielita, Jerry Cornell, et al.
Pediatric Blood & Cancer
|
July 13, 2011
Haploidentical non-myeloablative stem cell transplantation as salvage for graft failure in a patient with juvenile myelomonocytic leukemia
Guilherme F Perini, Fábio R Kerbauy, Juliana Folloni Fernandes, et al.
The Journal of Biological Chemistry
|
November 25, 1985
The biosynthesis, processing, and secretion of laminin by human choriocarcinoma cells
B P Peters, R J Hartle, R F Krzesicki, et al.
The Journal of Biological Chemistry
|
February 10, 1980
Synthesis and secretion of human chorionic gonadotropin subunits by cultured human malignant cells
R W Ruddon, C A Hanson, A H Bryan, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 21, 2017
Pathogenesis of chronic cluster headache and bouts: role of tryptamine, arginine metabolism and α<sub>1</sub>-agonists
G D'Andrea, G Bussone, P Di Fiore, et al.
Neuro-Oncology Advances
|
April 30, 2026
Phase 1 LITESPARK-001 study of belzutifan in participants with advanced solid tumors: Results of the glioblastoma expansion cohort
Roy E Strowd, Macarena de la Fuente, Todd M Bauer, et al.
Cancer Research
|
July 15, 1994
N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts
I Nishimori, F Perini, K P Mountjoy, et al.
Future Oncology (London, England)
|
October 26, 2023
LITESPARK-012: pembrolizumab plus lenvatinib with or without belzutifan or quavonlimab for advanced renal cell carcinoma
Toni K Choueiri, Thomas Powles, Martin H Voss, et al.
European Urology Oncology
|
August 15, 2019
Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden
Tushar Srivastava, Vimalanand S Prabhu, Haojie Li, et al.
Page
of 16